English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions?

von Kodolitsch, Y., Rybczynski, M., Bernhardt, A., Mir, T. S., Treede, H., Dodge-Khatami, A., et al. (2010). Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions? European Journal for Vascular Medicine, 39(1), 17-32. doi:10.1024/0301-1526/a000002.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Vasa

Files

show Files

Locators

show

Creators

show
hide
 Creators:
von Kodolitsch, Y., Author
Rybczynski, M., Author
Bernhardt, A., Author
Mir, T. S., Author
Treede, H., Author
Dodge-Khatami, A., Author
Robinson, P. N.1, Author           
Sheikhzadeh, S., Author
Reichenspurner, H., Author
Meinertz, T., Author
Affiliations:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              

Content

show
hide
Free keywords: bicuspid aortic valve FBN1 Loeys-Dietz syndrome Marfan syndrome NOTCH1 TGFBR1
 Abstract: Marfan syndrome (MFS) is a disorder of the connective tissue that is inherited in an autosomal dominant fashion and that is classically caused by mutations in the gene coding for fibrillin-1, FBN1. The high mortality of untreated MFS results almost exclusively from aortic complications such as aortic dissection and rupture. However, more than half of patients with Marfan-like features do not have MFS, but have other diseases including inherited aortic aneurysms and dissections (TAAD). We elucidate the increasing spectrum of syndromes associated with Marfan-like features and discuss the clinical implications of these diseases. We performed a systematic review to tabulate all known inherited diseases and syndromes carrying a risk for thoracic aortic disease. We discuss evidence that different syndromes with different causative genes and mutations have different prognoses and profiles of cardiovascular manifestations. We conclude that future decisions for optimized management of patients with inherited TAAD require a comprehensive clinical and genetic work-up.

Details

show
hide
Language(s): eng - English
 Dates: 2010-02-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: European Journal for Vascular Medicine
  Alternative Title : Vasa
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 39 (1) Sequence Number: - Start / End Page: 17 - 32 Identifier: ISSN: 0301-1526